Title : Reversal of bortezomib resistance in myelodysplastic syndrome cells by MAPK inhibitors.

Pub. Date : 2014

PMID : 24608798






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we report that bortezomib (BTZ), a proteasome inhibitor that has been used to treat plasma cell myeloma, induced G2/M phase cycle arrest in the MDS cell line SKM-1 through upregulation of Wee1, a negative regulator of G2/M phase transition. Bortezomib sodium voltage-gated channel alpha subunit 4 Homo sapiens
2 Here, we report that bortezomib (BTZ), a proteasome inhibitor that has been used to treat plasma cell myeloma, induced G2/M phase cycle arrest in the MDS cell line SKM-1 through upregulation of Wee1, a negative regulator of G2/M phase transition. Bortezomib sodium voltage-gated channel alpha subunit 4 Homo sapiens
3 Treatment by BTZ led to reduced SKM-1 cell viability as well as increased apoptosis and autophagy. Bortezomib sodium voltage-gated channel alpha subunit 4 Homo sapiens